The global Diaphragm Pacing Therapy System Market size is predicted to reach USD 7.57 million by 2027 according to this new study. The report “Diaphragm Pacing Therapy System Market Share, Size, Trends, Industry Analysis Report, By Product Type (External diaphragm pacemaker, Diaphragm pacemaker); By Application (SCI, ALS, and Others); By Regions; Segment Forecast, 2020 -2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Diaphragm pacing is the less weighted battery-powered devices that works electrically and stimulates to nerves and diaphragm muscles. This allows diaphragm to contract flexibly so that air is filled into lungs and assist patients to breathe conveniently and smoothly. Diaphragm pacing includes affixing four electrodes into diaphragm muscle and one more fifth electrode just under the skin besides the other electrodes. The electrodes are further united to an external stimulator to allow an ongoing electrical impulse to the electrodes, resulting in contraction of diaphragm aids in smooth and normal breathing.
A serious ventilator-dependent person requires two mechanical ventilators, first as a primary and second as a contingency backup. Such machines need a significant amount of disposable supplies to operate accurately and securely. Once the pacing is done the patient is able to remove one of the ventilators, as the one should keep for emergency, and reducing a significant section of the associated supplies. Considering yearly replacement of external antennas, the monthly replacement of batteries, and situational supplies such as tape, alcohol preps, a diaphragm pacing system costs nearly USD1,000 per year or even less than that to operate. Rental of a mechanical ventilator and the costs of its disposables starts from USD 1,500 to USD 2,500 every month. Thus, the implantation of a diaphragm pacing system significantly have a return of investment of 3-4 years, and save USD 18,000 to USD 30,000 every year.
The major driving factors of market are increasing new product developments, awareness amongst the citizens regarding the diaphragm pacing therapies, rising healthcare investments and need for technological advancement in healthcare sector. Additionally, increasing prevalence of amyotrophic lateral sclerosis (ALS) and Spinal Cord injury (SCI) surges the market growth. Moreover, increasing favorable regulations by the government for the approval of new products and rising reimbursement by the government and various private institution surges the market growth of diaphragm pace therapy system market globally. Further, rising strong product pipelines and clinical trials contributes significant growth to the diaphragm pace therapy market globally.
The increasing COVID-19 cases worldwide also contributes lucrative growth in the concerned market as COVID-19 treatment requires ventilators for the patients to breath and these DPTS are alternatives of ventilators hence, Diaphragm Pacing Therapy System allow normal breathing to the patients. Moreover, increasing research and development activities and rising awareness amongst the general public about the product.
Market participants such as Avery Biomedical Devices, Inc., Lungpacer Medical, Atrotech, Synapse Biomedical, and among others, are some of the key players operating in the global market. For instance, in April 2020, Lungpacer Medical got the U.S. FDA early market access clearance for the diaphragm pacing therapy system to assist in treating COVID-19 patients. These devices can be used as a substitute to the mechanical ventilator for patients with phrenic nerves, and diaphragm. Such initiative by the key market players helps them to increase their market share in the competitive market of Diaphragm Pacing Therapy System, globally.
The publisher has segmented the Diaphragm Pacing Therapy System market report on the basis of product type, application, and region
External Diaphragm Pacemaker
Diaphragm Pacemaker
Amyotrophic lateral sclerosis (ALS)
Spinal cord injuries (SCI)
Others
North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Spain
Netherlands
Austria
Asia Pacific
China
India
Japan
South Korea
Central & South America
Mexico
Brazil
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
A serious ventilator-dependent person requires two mechanical ventilators, first as a primary and second as a contingency backup. Such machines need a significant amount of disposable supplies to operate accurately and securely. Once the pacing is done the patient is able to remove one of the ventilators, as the one should keep for emergency, and reducing a significant section of the associated supplies. Considering yearly replacement of external antennas, the monthly replacement of batteries, and situational supplies such as tape, alcohol preps, a diaphragm pacing system costs nearly USD1,000 per year or even less than that to operate. Rental of a mechanical ventilator and the costs of its disposables starts from USD 1,500 to USD 2,500 every month. Thus, the implantation of a diaphragm pacing system significantly have a return of investment of 3-4 years, and save USD 18,000 to USD 30,000 every year.
The major driving factors of market are increasing new product developments, awareness amongst the citizens regarding the diaphragm pacing therapies, rising healthcare investments and need for technological advancement in healthcare sector. Additionally, increasing prevalence of amyotrophic lateral sclerosis (ALS) and Spinal Cord injury (SCI) surges the market growth. Moreover, increasing favorable regulations by the government for the approval of new products and rising reimbursement by the government and various private institution surges the market growth of diaphragm pace therapy system market globally. Further, rising strong product pipelines and clinical trials contributes significant growth to the diaphragm pace therapy market globally.
The increasing COVID-19 cases worldwide also contributes lucrative growth in the concerned market as COVID-19 treatment requires ventilators for the patients to breath and these DPTS are alternatives of ventilators hence, Diaphragm Pacing Therapy System allow normal breathing to the patients. Moreover, increasing research and development activities and rising awareness amongst the general public about the product.
Market participants such as Avery Biomedical Devices, Inc., Lungpacer Medical, Atrotech, Synapse Biomedical, and among others, are some of the key players operating in the global market. For instance, in April 2020, Lungpacer Medical got the U.S. FDA early market access clearance for the diaphragm pacing therapy system to assist in treating COVID-19 patients. These devices can be used as a substitute to the mechanical ventilator for patients with phrenic nerves, and diaphragm. Such initiative by the key market players helps them to increase their market share in the competitive market of Diaphragm Pacing Therapy System, globally.
The publisher has segmented the Diaphragm Pacing Therapy System market report on the basis of product type, application, and region
Diaphragm Pacing Therapy System Market by Product Type (Revenue-USD Million, 2016-2027)
External Diaphragm Pacemaker
Diaphragm Pacemaker
Diaphragm Pacing Therapy System Market by Application (Revenue-USD Million, 2016-2027)
Amyotrophic lateral sclerosis (ALS)
Spinal cord injuries (SCI)
Others
Diaphragm Pacing Therapy System Market Regional Outlook (Revenue-USD Million, 2016-2027)
North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Spain
Netherlands
Austria
Asia Pacific
China
India
Japan
South Korea
Central & South America
Mexico
Brazil
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Frequently Asked Questions about the Diaphragm Pacing Therapy System Market
What is the estimated value of the Diaphragm Pacing Therapy System Market?
What is the growth rate of the Diaphragm Pacing Therapy System Market?
What is the forecasted size of the Diaphragm Pacing Therapy System Market?
Who are the key companies in the Diaphragm Pacing Therapy System Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 107 |
| Published | November 2020 |
| Forecast Period | 2020 - 2027 |
| Estimated Market Value ( USD | $ 4.9 Million |
| Forecasted Market Value ( USD | $ 7.57 Million |
| Compound Annual Growth Rate | 5.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 4 |
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Diaphragm Pacing Therapy Systems Market Insights
5. Diaphragm Pacing Therapy Systems Market Assessment by Product
6. Global Diaphragm Pacing Therapy Systems Market, by Application
7. Diaphragm Pacing Therapy Systems Market Assessment by Geography
8. Competitive Landscape
9. Company Profiles
List of Tables
List of Figures
Companies Mentioned
- Avery Biomedical Devices Inc.
- Lungpacer Medical
- Atrotech
- Synapse Biomedical
